Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis

Alpha-glucosidase inhibitors are widely used especially in Asian countries as a treatment option for type 2 diabetes patients with high postprandial glycemia (PPG). The higher carbohydrate in the Indian diets lead to greater prandial glycemic excursion, increased glucosidase, and incretin activity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Sahay, R. K., Schnell, O., Sheu, W. H. H., Grzeszczak, W., Watada, H., Soegondo, S., Yamamoto, N., Weng, J., Rathod, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830342/
https://www.ncbi.nlm.nih.gov/pubmed/24251196
http://dx.doi.org/10.4103/2230-8210.119634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830342/
https://www.ncbi.nlm.nih.gov/pubmed/24251196
http://dx.doi.org/10.4103/2230-8210.119634

Ejemplares similares